http://web.archive.org/web/20130618003517id_/http://www.dailymail.co.uk/health/article-2340894/New-AIDS-prevention-pill-cut-infection-rates-IV-drug-users-50.html

by @entity0 published : 06:00 est , 13 june 2013 updated : 06:58 est , 13 june 2013 a new aids prevention drug should be approved for use by intravenous drug users , @entity2 health experts have said a new aids prevention drug should be approved for use by intravenous drug users , @entity2 health experts have said			1
the anti-retroviral drug , which has recently been approved for prescription to some other high - risk groups , could soon be given to people who inject heroin and methamphetamine			1
after reviewing the results of a study , carried out by @entity17 ( @entity17 ) and the @entity19 government , health officials recommended that the drug , tenofovir , should be taken daily by drug users			1
it has already been approved for use by high - risk gay men and heterosexual couples , @entity23 reported			1
to conduct the study , scientists followed more than 2,400 drug users at clinics across @entity30 , in @entity19			1
@entity31 were given a daily dose of tenofovir , which is sold as @entity34 , while the other half were given a placebo			0
the patients were followed for four years during which time 17 of those taking the preventative drug contracted @entity40 , while 33 of the people taking the placebo became infected			0
therefore , it was concluded that the drug reduces @entity40 risk by 50 per cent			1
dr @entity46 , director of aids prevention for the @entity17 , told @entity23 that ‘ this study completes the story ’ about how @entity40 drugs can protect people at highest risk of infection			2
currently , the only hiv prevention drug which is available for use in the @entity2 is @entity56 which is prohibitively expensive at $ 14,000 a year			2
the tenofovir which was used in the study costs just $ 360 a year per patient			0
according to researcher , dr @entity61 : ' we now know that pre-exposure prophylaxis can be a potentially vital option for @entity40 prevention in people at very high risk for infection , whether through sexual transmission or injecting drug use			2
' adherence was a key factor determining efficacy in our trial among people who inject drugs			0
' the drug , tenofovir , which is sold as @entity34 , reduces a person 's risk of contracting @entity40 ( pictured ) by up to 50 per cent scientists are also working on an hiv vaccine but the @entity2 government recently stopped trials of the experimental vaccine after an independent review found it did not prevent @entity40 infection or reduce the amount of @entity40 in the blood			1
the research , started in 2009 , it is just the latest in a series of failed attempts to develop a vaccine for the virus			0
in the @entity2 intravenous drug users account for about one in 13 new hiv infections but in the countries of @entity98 and central @entity99 , they make up 80 per cent of those newly infected			1
according to the @entity102 96,000 people in the @entity101 are currently living with @entity40			0
of these people , 22,600 are thought to be unaware of their infection			0
in 2011 , only one per cent of people with @entity40 in the @entity101 died			0
the biggest group of @entity40 positive people in the @entity101 are men who have sex with men - they account for about 40,000 of the @entity40 infected population .			2

@entity2 health experts say tenofovir should be approved for use by drug users
is already approved for use by high - risk gay men and heterosexual couples
it reduces hiv infection risk by up to 50 per cent

@entity17:CDC
@entity2:U.S.
@entity0:Emma Innes
@entity34:Viread
@entity23:CBS News
@entity46:Jonathan Mermin
@entity19:Thailand
@entity101:UK
@entity102:National AIDS Trust
@entity40:HIV
@entity56:Truvada
@entity99:Asia
@entity98:Eastern Europe
@entity30:Bangkok
@entity31:Half
@entity61:Michael Martin